Nuzenio

Oncodaily Fda

Oncodaily Fda entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 19 latest news signals 1 publisher sources 100/100 entity strength

Latest news

ACS CAN Raises Alarm Over FDA Authorization of Flavored Nicotine Pouches - OncodailyOncodaily · Sat, 08 Aug 2026 18:35:29 GMT Rami Manochakian: Lurbinectedin Faces FDA Withdrawal After Negative Phase 3 Trial in SCLC - OncodailyOncodaily · Sat, 08 Aug 2026 09:12:26 GMT Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma - OncodailyOncodaily · Fri, 07 Aug 2026 18:18:14 GMT FDA Grants Accelerated Approval to Tudriqev Plus Nivolumab for Advanced Melanoma - OncodailyOncodaily · Fri, 07 Aug 2026 16:26:41 GMT Nieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - OncodailyOncodaily · Fri, 07 Aug 2026 11:52:07 GMT Replimune Announces FDA Approval of Oncolytic Immunotherapy - OncodailyOncodaily · Fri, 07 Aug 2026 08:30:33 GMT FDA Authorizes Marketing of Four New Nicotine Pouch Products - OncodailyOncodaily · Thu, 06 Aug 2026 18:59:20 GMT FDA Held Webinar on Proposed Path to Faster First-in-Human Trials - OncodailyOncodaily · Thu, 06 Aug 2026 17:41:24 GMT

Timeline

Sat, 08 Aug 2026 18:35:29 GMTACS CAN Raises Alarm Over FDA Authorization of Flavored Nicotine Pouches - Oncodaily

Sat, 08 Aug 2026 09:12:26 GMTRami Manochakian: Lurbinectedin Faces FDA Withdrawal After Negative Phase 3 Trial in SCLC - Oncodaily

Fri, 07 Aug 2026 18:18:14 GMTThird Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma - Oncodaily

Fri, 07 Aug 2026 16:26:41 GMTFDA Grants Accelerated Approval to Tudriqev Plus Nivolumab for Advanced Melanoma - Oncodaily

Fri, 07 Aug 2026 11:52:07 GMTNieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - Oncodaily

Fri, 07 Aug 2026 08:30:33 GMTReplimune Announces FDA Approval of Oncolytic Immunotherapy - Oncodaily

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Oncodaily8 live mentions Oncodaily Oncodaily6 live mentions FDA6 live mentions FDA Approval5 live mentions PSMA4 live mentions Advanced Melanoma3 live mentions Advanced Melanoma Oncodaily3 live mentions Approval3 live mentions Flavored Nicotine Pouches2 live mentions Lurbinectedin Faces FDA2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oncodaily Fda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.